Search

Hong Tiesheng L Ma

from San Jose, CA
Age ~65
Get Report
Also known as:
Hong Tiesheng Ma, Hong M Li, Ma Ma, Yanhong Ma, Zhong Ma, Yinghong Ma, Hong Zheng, Hong Zhang, Yan Hongma
Related to:
Hongqing Yang, 50
Connected to:
Aileen F Ma, 33Alex Ma, 36Alexander C Ma, 76Aliza X Ma, 38Anila T Ma, 42Anny S Ma, 57Arick C Ma, 51Arleen C Ma, 49Bao P Ma, 73Barry K Ma, 69

Hong Ma Phones & Addresses

  • San Jose, CA
  • Sunnyvale, CA
  • Cupertino, CA
  • Roosevelt Corner, CA
  • Athens, OH
  • Boston, MA
  • Santa Clara, CA
  • Los Angeles, CA

Resumes

Resumes

Hong Ma Photo 1

Hong Ma

View page
Work:
Cathlic Health Partner 2010 - 2011
Coordinator
Chp 2010 - 2011
Coordinator
Hong Ma Photo 2

Hong Ma

View page
Hong Ma Photo 3

Hong Ma

View page
Location:
United States
Hong Ma Photo 4

Hong Ma

View page
Location:
United States
Hong Ma Photo 5

Hong Ma

View page
Location:
United States
Hong Ma Photo 6

Hong Ma

View page
Location:
United States
Hong Ma Photo 7

Hong Ma San Francisco, CA

View page
Work:
Speedmark Transportation Inc
Burlingame, CA
Apr 2011 to Mar 2012
Accountant and Intentional Coordinator
Rockport Healthcare Centers
Oakland, CA
Feb 2007 to Jul 2010
Accountant
Prepared Federal and State

Feb 2007 to Apr 2007
Tax Preparer
GTT International Inc
San Francisco, CA
Jan 2007 to Feb 2007
Sales Clerk
California State University East Bay Library
Hayward, CA
Sep 2006 to Dec 2006
Library Assistant
Education:
California State University East Bay
2006
B.S. in Business Administration

Business Records

Name / Title
Company / Classification
Phones & Addresses
Hong Ma
President
Le Juin, Inc
860 Meridian Bay Ln, San Mateo, CA 94404
Hong Duo Ma
President
HONG WOO CHINESE RESTAURANT
649 San Mateo Ave, San Bruno, CA 94066
1341 Stockton St, San Francisco, CA 94133
Hong Biao Ma
President
R B M REALTY, INC
1754 Technology Dr STE #210, San Jose, CA 95110
Hong Xiz Ma
BIZ CONSULTANTS USA, LLC
Hong Xia Ma
HOME CLINIC USA, LLC
Hong B. Ma
President
Rbm Realty Inc
Real Estate Agent/Manager
4556 Cheeney St, Santa Clara, CA 95054
Hong Ma
President
HERON, INC
Junior College
1289 E Hillsdale Blvd #9, San Mateo, CA 94404
(650) 438-5019
Hong B. Ma
Principal
Realtorcom
Real Estate Agent/Manager
4556 Cheeney St, Santa Clara, CA 95054

Publications

Us Patents

Sustained Release Of Apo A-I Mimetic Peptides And Methods Of Treatment

View page
US Patent:
8101565, Jan 24, 2012
Filed:
Nov 27, 2007
Appl. No.:
11/946026
Inventors:
Katsuyuki Murase - Cupertino CA, US
Syed F. A. Hossainy - Fremont CA, US
Irina Astafieva - Palo Alto CA, US
Li Zhao - Mountain View CA, US
Hong Ma - Cupertino CA, US
Assignee:
Abbott Cardiovascular Systems Inc. - Santa Clara CA
International Classification:
C07K 14/00
A61K 38/00
US Classification:
514 2, 530300
Abstract:
A method including advancing a delivery device through a lumen of a blood vessel to a particular region in the blood vessel; and introducing a composition including a sustained-release carrier and an apolipoprotein A-I (apo A-I) synthetic mimetic peptide into a wall of the blood vessel at the particular region or a perivascular site, wherein the peptide has a property that renders the peptide effective in reverse cholesterol transport. A composition including an apolipoprotein A-I (apo A-I) synthetic peptide, or combination of an apo A-I synthetic mimetic peptide and an Acyl CoA cholesterol: acyltransferase (ACAT) inhibitor in a form suitable for delivery into a blood vessel, the peptide including an amino acid sequence in an order reverse to an order of various apo A-I mimetic peptides, or endogenous apo A-I analogs, or a chimera of helix 1 and helix 9 of endogenous apo A-I.

Dual-Targeted Drug Carriers

View page
US Patent:
20090148491, Jun 11, 2009
Filed:
Dec 5, 2007
Appl. No.:
11/951152
Inventors:
Syed F.A. Hossainy - Fremont CA, US
Dariush Davalian - San Jose CA, US
Jinping Wan - Sunnyvale CA, US
Hong Ma - Mountain View CA, US
Assignee:
Abbott Cardiovascular Systems Inc. - Santa Clara CA
International Classification:
A61K 9/00
A61P 9/10
A61P 9/00
US Classification:
424423
Abstract:
The present invention relates to implantable medical devices containing surface-treated, dual-targeted drug carriers for treating vascular diseases.

Dual-Targeted Drug Carriers

View page
US Patent:
20150086603, Mar 26, 2015
Filed:
Dec 1, 2014
Appl. No.:
14/557299
Inventors:
- Santa Clara CA, US
Dariush Davalian - San Jose CA, US
Jinping Wan - Irvine CA, US
Hong Ma - Mountain View CA, US
International Classification:
A61L 31/06
A61L 31/00
US Classification:
424423
Abstract:
The present invention relates to implantable medical devices containing surface-treated, dual-targeted drug carriers for treating vascular diseases.

Multiple Growth Factor Compositions, Methods Of Fabrication, And Methods Of Treatment

View page
US Patent:
20140199377, Jul 17, 2014
Filed:
Mar 18, 2014
Appl. No.:
14/218279
Inventors:
- Santa Clara CA, US
Florian N. Ludwig - Zurich, CH
Evgenia Mandrusov - Santa Clara CA, US
Liangxuan Zhang - Sunnyvale CA, US
Hong Ma - Cupertino CA, US
Jinping Wan - Sunnyvale CA, US
Shubhayu Basu - Solon OH, US
Assignee:
Abbott Cardiovascular Systems Inc. - Santa Clara CA
International Classification:
A61K 38/30
A61K 9/06
A61K 38/18
A61K 45/06
A61K 9/127
A61K 35/34
US Classification:
424450, 424 937, 514 86
Abstract:
Disclosed are compositions with sustained-release carriers associated with at least two different types of growth factors and methods of fabrication and treatments thereof. In some embodiments, simultaneous release of the growth factors may be preferred while in other embodiments, sequential release of the growth factors may be preferred. Application of at least two growth factors to an injury site, e.g., compromised cardiac tissue caused by, for example, myocardial infarction or ischemic heart failure, may better mimic and induce the complex growth factor signaling pathways necessary to improve cardiac function. When applied to a patient after a myocardial infarction or ischemic heart failure, multiple growth factors within a sustained-release carrier platform or platforms may cause a synergistic effect on injected cells intending to alleviate left ventricle remodeling. Methods of treatment include percutaneous, sub-xiphoid, and open chest methods using catheters and/or syringes.
Control profile
Hong Tiesheng L Ma from San Jose, CA, age ~65 Get Report